Nu-Med Plus (NUMD) Non Operating Interest Expenses (2012 - 2026)
Nu-Med Plus' (NUMD) quarterly Non Operating Interest Expenses came in at $2774.0 in Q2 2026, up 122.63% year-over-year from $1246.0 in Q2 2025, and down 2.91% quarter-over-quarter from $2857.0 in Q4 2025.
Powered by 
Analysis
Nu-Med Plus (NUMD) Non Operating Interest Expenses (2012 - 2026) Analysis & Trends
Nu-Med Plus has disclosed Non Operating Interest Expenses across 13 years of filings, most recently posting $2774.0 for Q2 2026.
- In Q2 2026, Non Operating Interest Expenses rose 122.63% year-over-year to $2774.0; the TTM figure through Jun 2026 stood at $8768.0 (up 75.36% YoY), while the FY2025 annual figure was $7227.0, up 44.14% from the prior year.
- Non Operating Interest Expenses came in at $2774.0 for Q2 2026 at Nu-Med Plus, down from $2857.0 in the prior quarter.
- In the past five years, Non Operating Interest Expenses ranged from a high of $2857.0 in Q4 2025 to a low of $1233.0 in Q1 2023.
- Average Non Operating Interest Expenses over 4 years is $1539.7, with a median of $1260.0 recorded in 2023.
- The largest YoY upside for Non Operating Interest Expenses was 126.57% in 2025 against a maximum downside of 1.12% in 2025.
- Over 4 years, Non Operating Interest Expenses stood at $1260.0 in 2023, then climbed by 0.08% to $1261.0 in 2024, then soared by 126.57% to $2857.0 in 2025, then fell by 2.91% to $2774.0 in 2026.
- Per Business Quant data, the three most recent Non Operating Interest Expenses figures were $2774.0 in Q2 2026, $2857.0 in Q4 2025, and $1891.0 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Interest Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | 351.00 Mn |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | - |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | 186.00 Mn |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | 141.00 Mn |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | 96.00 Mn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | - |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | -53.00 Mn |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | - |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | 15.80 Mn |
| 10 | Nu-Med Plus | 1.67 Mn | 1.67 Mn | - | 2,774.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2,774.00 |
| Dec 31, 2025 | 2,857.00 |
| Sep 30, 2025 | 1,891.00 |
| Jun 30, 2025 | 1,246.00 |
| Mar 31, 2025 | 1,233.00 |
| Dec 31, 2024 | 1,261.00 |
| Sep 30, 2024 | 1,260.00 |
| Jun 30, 2024 | 1,247.00 |
| Mar 31, 2024 | 1,247.00 |
| Dec 31, 2023 | 1,260.00 |
| Sep 30, 2023 | 1,260.00 |
| Jun 30, 2023 | 1,247.00 |
| Mar 31, 2023 | 1,233.00 |
| Dec 31, 2020 | 2,214.00 |
| Sep 30, 2020 | 4,066.00 |
| Jun 30, 2020 | 4,021.00 |
| Mar 31, 2020 | 4,021.00 |
| Dec 31, 2019 | 4,177.00 |
| Sep 30, 2019 | 4,363.00 |
| Jun 30, 2019 | -4,399.00 |